NEU neuren pharmaceuticals limited

Ann: Disclosure under Listing Rule 4.3D, page-23

  1. 547 Posts.
    lightbulb Created with Sketch. 1345
    hi rastus
    604, which recorded the change in the share of the seller, was regularly communicated to the market, as the selling party held a 8.37% pre-sale. however, having been sold a quota equal to 1.87%, I do not believe that there are the obligations to communicate its status with a further 604 as less than 5%. on the contrary, the company will have to register with T20 in the annual report in April, noting that 1.87% is classified as a substantial holder at the 7th / 8th place in the ranking.
    the list that will be published in April is the one registered at the end of March, so during these hours. I did not know that the documentation could be requested from the CFO; it would be interesting to know it in advance, even if I believe that at this moment it is particularly sensitive material for the market.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.100(0.80%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.44 $12.73 $12.13 $11.07M 885.6K

Buyers (Bids)

No. Vol. Price($)
1 1215 $12.52
 

Sellers (Offers)

Price($) Vol. No.
$12.54 804 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.